Omnia SanaPlant Comparison
Noni vs Panax Ginseng
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Noni and Panax Ginseng: they share 7 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cold & flu, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Noni | Panax Ginseng | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 5/10 | Stronger for Panax Ginseng |
| Blood sugar / diabetes support | 2/10 | 5/10 | Stronger for Panax Ginseng |
| Cold & flu | 2/10 | 5/10 | Stronger for Panax Ginseng |
| Immune support | 2/10 | 5/10 | Stronger for Panax Ginseng |
| Inflammation (general) | 2/10 | 5/10 | Stronger for Panax Ginseng |
| Metabolic support | 2/10 | 5/10 | Stronger for Panax Ginseng |
| Skin irritation | 2/10 | 5/10 | Stronger for Panax Ginseng |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
A major phytochemical class of noni fruit and leaf, studied for antioxidant and anti-inflammatory activity.
Found mainly in the root and, at lower levels, the fruit; studied for anticancer and antimicrobial activity.
Fruit polysaccharides studied for gut-microbiota-modulating and anti-inflammatory effects in animal models of inflammatory bowel disease.
A phenolic coumarin found in the fruit, studied for anti-inflammatory and vascular effects.
The principal bioactive triterpene saponins of the root, considered responsible for most of ginseng's adaptogenic, neuroprotective and immunomodulatory activity; the ratio of protopanaxadiol- to protopanaxatriol-type ginsenosides differs between fresh, white and red ginseng.
Contribute to the immunomodulatory activity of the root.
Minor constituents contributing to the aroma and antioxidant activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
Safety, Cautions & Contraindications
Generally safe in moderate amounts. High potassium content — use caution in renal disease. Rare cases of hepatotoxicity reported with excessive consumption. May interact with warfarin (due to vitamin K content). Avoid during pregnancy.
Duke (2002) rates noni as +++ and notes analgesic, antirheumatic, antiarthritic, antitumor, antispasmodic, and hypotensive activities at the experimental level (score 1). Traditional Polynesian and South Asian medicine values it as a broad-spectrum tonic. The plant contains morindine, proxeronine, and damnacanthal, which are under investigation for immunomodulatory and anti-tumor effects. Duke notes that noni fruit can be consumed as food and is generally safe, though the juice has a strong unpleasant odor and taste. No significant toxicity has been reported with regular food consumption (Duke, 2002).
Generally well tolerated in short-term use (up to 3 months). May cause insomnia, headache, or gastrointestinal upset at high doses. Avoid during pregnancy and breastfeeding. May interact with warfarin, MAOIs, and diabetic medications. Not recommended for continuous use without breaks.
Duke (2002) rates Korean/Oriental ginseng (Panax ginseng) as highly active with clinical support for adaptogenic, immunostimulant, and performance-enhancing effects. Commission E approves standardized ginseng root extract (4–7% ginsenosides) as a tonic for fatigue and during convalescence. Dose: 200–600 mg standardized extract daily. Duke cautions about 'Ginseng Abuse Syndrome' (GAS) with overdose — symptoms include hypertension, insomnia, edema, and nervousness. Drug interactions are notable: ginseng potentiates MAOIs and may interact with warfarin, digoxin, and stimulants. Cycle use (2–3 weeks on, 2 weeks off) is recommended (Duke, 2002).
External Ids
Botanical Description
Small evergreen tree or shrub (Rubiaceae), 3-10 m tall, with large, glossy, dark green, elliptical leaves marked by prominent parallel veins. Small, white, tubular, fragrant flowers are borne in dense rounded heads, developing into a compound fleshy fruit (syncarp) that is warty, semi-translucent and yellow-white when ripe, with a strong, pungent, cheese-like odour.[1]
Slow-growing perennial herb (Araliaceae), 30-60 cm tall, harvested at 4 years of age or older. A single erect stem bears a whorl of palmately compound leaves, each with 3-5 toothed leaflets, at its top. Small greenish-white flowers are borne in a single terminal umbel, followed by small red berries. The fleshy, often forked or human-shaped taproot - the origin of the name 'ginseng' ('renshen', man-root) - is the medicinal part.[3]
Habitat
Native to Southeast Asia and Australasia, and dispersed across the Pacific islands and into India and the Caribbean by early Polynesian voyagers and subsequent cultivation; grows in coastal areas, open and disturbed forest, and even on bare lava flows, tolerating poor, saline and drought-prone soils.[1, 6]
Native to the cool-temperate deciduous mountain forests of Manchuria, Korea and the Russian Far East. Historically wild-harvested, it is now predominantly cultivated, mainly in Korea and China, under artificial shade for several years before harvest.[1]
Harvesting
Ripe fruit is hand-picked as it softens and turns yellow-white, then traditionally left to further ripen or ferment for juice production; leaves and root are also traditionally gathered.[6]
The root is harvested after at least 4-6 years of growth, once its ginsenoside content is fully developed. Roots are either air-dried as 'white ginseng' or steamed and then dried as 'red ginseng', a processing step that alters the ginsenoside profile.[3]
Traditional Uses
Noni has an extensive Polynesian, South Asian and Southeast Asian traditional-medicine history, used as a broad-spectrum tonic for pain, inflammation, infection and immune support, and traditionally for diabetes and skin complaints. The fermented fruit juice is the most widely used modern preparation, now studied for antioxidant, anti-inflammatory, immunomodulatory and metabolic effects supporting several of these traditional uses.[1, 6]
Ginseng is one of the most celebrated tonic herbs of East Asian traditional medicine, used for millennia as a general adaptogen to restore vitality, support recovery from illness and improve stamina and cognitive performance. Modern clinical research supports adaptogenic, immunomodulatory, antioxidant, neuroprotective and mild antidiabetic effects consistent with this traditional use.[1, 7]
Preparations
Commission E-recognised standardised extract (4-7% ginsenosides), the most clinically studied preparation.
Traditional processed form (steamed then dried), which alters and concentrates the ginsenoside profile compared with white (unprocessed) ginseng.
Dosage
Commercial noni juice is typically taken in modest daily amounts (a few tablespoons); given rare reports of hepatotoxicity with excessive or prolonged intake, avoid high doses, especially with pre-existing liver disease. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
Pairings
Not documented
Ginseng and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 20]
Ginseng and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 21]
References & Sources
- Potterat, O. and Hamburger, M (2007) 'Morinda citrifolia (Noni) fruit--phytochemistry, pharmacology, safety', Planta Medica, 73(3), pp. 191-199. doi:10.1055/s-2007-967115 Meta-analysis / review
https://doi.org/10.1055/s-2007-967115 - Brown, A.C (2012) 'Anticancer activity of Morinda citrifolia (Noni) fruit: a review', Phytotherapy Research, 26(10), pp. 1427-1440. doi:10.1002/ptr.4595 Meta-analysis / review
https://doi.org/10.1002/ptr.4595 - Almeida-Souza, F., de Souza, C.S., Taniwaki, N.N., Silva, J.J. and others (2016) 'Morinda citrifolia Linn. fruit (Noni) juice induces an increase in NO production and death of Leishmania amazonensis amastigotes in peritoneal macrophages from BALB/c', Nitric Oxide, 58, pp. 51-58. doi:10.1016/j.niox.2016.06.004 Preclinical
https://doi.org/10.1016/j.niox.2016.06.004 - Wang, R., Wang, L., Wang, S., Wang, J. and others (2022) 'Phenolics from noni (Morinda citrifolia L.) fruit alleviate obesity in high fat diet-fed mice via modulating the gut microbiota and mitigating intestinal damage', Food Chemistry, 402, pp. 134232. doi:10.1016/j.foodchem.2022.134232 Preclinical
https://doi.org/10.1016/j.foodchem.2022.134232 - Yoshitomi, H., Zhou, J., Nishigaki, T., Li, W. and others (2020) 'Morinda citrifolia (Noni) fruit juice promotes vascular endothelium function in hypertension via glucagon-like peptide-1 receptor-CaMKKbeta-AMPK-eNOS pathway', Phytotherapy Research, 34(9), pp. 2341-2350. doi:10.1002/ptr.6685 Preclinical
https://doi.org/10.1002/ptr.6685 - Almeida, E.S., de Oliveira, D. and Hotza, D (2019) 'Properties and Applications of Morinda citrifolia (Noni): A Review', Comprehensive Reviews in Food Science and Food Safety, 18(4), pp. 883-909. doi:10.1111/1541-4337.12456 Meta-analysis / review
https://doi.org/10.1111/1541-4337.12456 - Kim, S.H., Seong, G.S. and Choung, S.Y (2020) 'Fermented Morinda citrifolia (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier Function', Nutrients, 12(1), pp. 249. doi:10.3390/nu12010249 Preclinical
https://doi.org/10.3390/nu12010249 - Jin, M.Y., Wu, X.Y., Li, M.Y., Li, X.T. and others (2021) 'Noni (Morinda citrifolia L.) Fruit Polysaccharides Regulated IBD Mice Via Targeting Gut Microbiota: Association of JNK/ERK/NF-kappaB Signaling Pathways', Journal of Agricultural and Food Chemistry, 69(35), pp. 10151-10162. doi:10.1021/acs.jafc.1c03833 Preclinical
https://doi.org/10.1021/acs.jafc.1c03833 - Lee, D., Yu, J.S., Huang, P., Qader, M. and others (2020) 'Identification of Anti-Inflammatory Compounds from Hawaiian Noni (Morinda citrifolia L.) Fruit Juice', Molecules, 25(21), pp. 4968. doi:10.3390/molecules25214968 Preclinical
https://doi.org/10.3390/molecules25214968 - Ma, L.D., Lin, G.B., Yang, L.B., Cao, J.L. and others (2021) 'Morinda citrifolia (Noni) Juice Suppresses A549 Human Lung Cancer Cells via Inhibiting AKT/Nuclear Factor-kappaB Signaling Pathway', Chinese Journal of Integrative Medicine, 27(9), pp. 688-695. doi:10.1007/s11655-020-3421-y Preclinical
https://doi.org/10.1007/s11655-020-3421-y - Hirazumi, A. and Furusawa, E (1999) 'An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia', 13(5), pp. 380--387. Preclinical
https://scholar.google.com/scholar?q=An%20immunomodulatory%20polysaccharide-rich%20substance%20from%20the%20fruit%20juice%20of%20Morinda%20citrifolia - Potterat, O. and Hamburger, M (2007) 'Morinda citrifolia (Noni) fruit — phytochemistry, pharmacology, safety', 73(3), pp. 191--199. doi:10.1055/s-2007-967115 Preclinical
https://doi.org/10.1055/s-2007-967115 - West, B.J., Jensen, C.J., Westendorf, J. and White, L.D (2006) 'A safety review of noni fruit juice', 71(8). doi:10.1111/j.1750-3841.2006.00164.x Traditional / reference
https://doi.org/10.1111/j.1750-3841.2006.00164.x - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Mancuso, C. and Santangelo, R (2017) 'Panax ginseng and Panax quinquefolius: From pharmacology to toxicology', Food and Chemical Toxicology, 107(Pt A), pp. 362-372. doi:10.1016/j.fct.2017.07.019 Meta-analysis / review
https://doi.org/10.1016/j.fct.2017.07.019 - Zhou, Z., Li, M., Zhang, Z., Song, Z. and others (2024) 'Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases', Journal of Ethnopharmacology, 334, pp. 118506. doi:10.1016/j.jep.2024.118506 Meta-analysis / review
https://doi.org/10.1016/j.jep.2024.118506 - Liu, H., Lu, X., Hu, Y. and Fan, X (2020) 'Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy', Pharmacological Research, 161, pp. 105263. doi:10.1016/j.phrs.2020.105263 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.105263 - Fan, S., Zhang, Z., Su, H., Xu, P. and others (2020) 'Panax ginseng clinical trials: Current status and future perspectives', Biomedicine & Pharmacotherapy, 132, pp. 110832. doi:10.1016/j.biopha.2020.110832 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2020.110832 - Ni, X.C., Wang, H.F., Cai, Y.Y., Yang, D. and others (2022) 'Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke', Redox Biology, 54, pp. 102363. doi:10.1016/j.redox.2022.102363 Preclinical
https://doi.org/10.1016/j.redox.2022.102363 - Arring, N.M., Millstine, D., Marks, L.A. and Nail, L.M (2018) 'Ginseng as a Treatment for Fatigue: A Systematic Review', Journal of Alternative and Complementary Medicine, 24(7), pp. 624-633. doi:10.1089/acm.2017.0361 Meta-analysis / review
https://doi.org/10.1089/acm.2017.0361 - Zhou, G., Wang, C.Z., Mohammadi, S., Sawadogo, W.R. and others (2023) 'Pharmacological Effects of Ginseng: Multiple Constituents and Multiple Actions on Humans', The American Journal of Chinese Medicine, 51(5), pp. 1085-1104. doi:10.1142/S0192415X23500507 Meta-analysis / review
https://doi.org/10.1142/S0192415X23500507 - Ramanathan, M.R. and Penzak, S.R (2017) 'Pharmacokinetic Drug Interactions with Panax ginseng', European Journal of Drug Metabolism and Pharmacokinetics, 42(4), pp. 545-557. doi:10.1007/s13318-016-0387-5 Meta-analysis / review
https://doi.org/10.1007/s13318-016-0387-5 - Li, J., Huang, Q., Chen, J., Qi, H. and others (2021) 'Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences', Frontiers in Pharmacology, 12, pp. 688490. doi:10.3389/fphar.2021.688490 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.688490 - Geng, J., Dong, J., Ni, H., Lee, M.S. and others (2010) 'Ginseng for cognition', Cochrane Database of Systematic Reviews, (12), pp. CD007769. doi:10.1002/14651858.CD007769.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD007769.pub2 - Attele, A.S., Wu, J.A. and Yuan, C.S (1999) 'Ginseng pharmacology: multiple constituents and multiple actions', 58(11), pp. 1685--1693. doi:10.1016/s0006-2952(99)00212-9 Traditional / reference
https://doi.org/10.1016/s0006-2952(99)00212-9 - Kiefer, D. and Pantuso, T (2003) 'Panax ginseng', 68(8), pp. 1539--1542. Traditional / reference
https://scholar.google.com/scholar?q=Panax%20ginseng - Park, H.J., Kim, D.H. and Park, S.J (2014) 'Ginseng in traditional herbal prescriptions', 38(1), pp. 1--7. doi:10.5142/jgr.2012.36.3.225 Randomized trial
https://doi.org/10.5142/jgr.2012.36.3.225 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Yuan, C.S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M. and Moss, J (2004) 'American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial', Annals of Internal Medicine, 141(1), pp. 23-27. doi:10.7326/0003-4819-141-1-200407060-00011 Randomized trial
https://doi.org/10.7326/0003-4819-141-1-200407060-00011 - Sotaniemi, E.A., Haapakoski, E. and Rautio, A (1995) 'Ginseng therapy in non-insulin-dependent diabetic patients', Diabetes Care, 18(10), pp. 1373-1375. doi:10.2337/diacare.18.10.1373 Randomized trial
https://doi.org/10.2337/diacare.18.10.1373 - Vuksan, V., Sievenpiper, J.L., Koo, V.Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z. and Vidgen, E (2000) 'American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus', Archives of Internal Medicine, 160(7), pp. 1009-1013. doi:10.1001/archinte.160.7.1009 Randomized trial
https://doi.org/10.1001/archinte.160.7.1009 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.